Transplant Infectious Diseases: A Review of the Scientific Registry of Transplant Recipients Published Data

被引:32
作者
Kotton, C. N. [1 ]
Huprikar, S. [2 ]
Kumar, D. [3 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02115 USA
[2] Ichan Sch Med Mt Sinai, New York, NY USA
[3] Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; CONSENSUS GUIDELINES; CYTOMEGALOVIRUS; OUTCOMES; PROPHYLAXIS; RISK; TRANSMISSION; FAILURE;
D O I
10.1111/ajt.14195
中图分类号
R61 [外科手术学];
学科分类号
摘要
The Scientific Registry of Transplant Recipients (SRTR) serves to collect data on organ transplants performed in the United States. Although the infectious diseases data are limited and include mostly pretransplant serologies and other nonspecific infection-related outcomes, this multicenter data collection allows for insightful national data and the ability to monitor trends over time. We reviewed the published concise reports for each organ type in SRTR reports containing data from 2005 to 2014, and summarized our findings with respect to cytomegalovirus (CMV), Epstein-Barr virus, posttransplant lymphoproliferative disorder (PTLD), hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, general infection, and prophylaxis. Our review highlights a few developments. While rates of donor-recipient CMV serology combinations remain fairly constant over time, there are generally more seronegative donors and recipients among living donor transplants. There has been a reduction in PTLD for pediatric transplant recipients. There has also been a slight reduction in anti-HBV core antibodypositive donor organs and stable reporting of HCV-positive donor organs and HIV-positive recipients.
引用
收藏
页码:1439 / 1446
页数:8
相关论文
共 34 条
[1]   Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation [J].
Arthurs, Supha K. ;
Eid, Albert J. ;
Pedersen, Rachel A. ;
Kremers, Walter K. ;
Cosio, Fernando G. ;
Patel, Robin ;
Razonable, Raymund R. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (06) :840-846
[2]   Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988-2004 [J].
Bate, Sheri Lewis ;
Dollard, Sheila C. ;
Cannon, Michael J. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (11) :1439-1447
[3]   Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant Recipients [J].
Coffin, C. S. ;
Stock, P. G. ;
Dove, L. M. ;
Berg, C. L. ;
Nissen, N. N. ;
Curry, M. P. ;
Ragni, M. ;
Regenstein, F. G. ;
Sherman, K. E. ;
Roland, M. E. ;
Terrault, N. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) :1268-1275
[4]   Seroprevalence of Epstein-Barr Virus Infection in US Children Ages 6-19, 2003-2010 [J].
Dowd, Jennifer Beam ;
Palermo, Tia ;
Brite, Jennifer ;
McDade, Thomas W. ;
Aiello, Allison .
PLOS ONE, 2013, 8 (05)
[5]   Intragraft Cytomegalovirus Protein Expression Is Associated With Reduced Renal Allograft Survival [J].
Dzabic, Mensur ;
Rahbar, Afsar ;
Yaiw, Koon-Chu ;
Naghibi, Mansour ;
Religa, Piotr ;
Fellstrom, Bengt ;
Larsson, Erik ;
Soderberg-Naucler, Cecilia .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (10) :969-976
[6]   Introduction: Infection in Solid Organ Transplant Recipients [J].
Fishman, J. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 :S3-S6
[7]   Introduction: Infections in Solid Organ Transplantation [J].
Green, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :3-8
[8]   KIDNEY [J].
Hart, A. ;
Smith, J. M. ;
Skeans, M. A. ;
Gustafson, S. K. ;
Stewart, D. E. ;
Cherikh, W. S. ;
Wainright, J. L. ;
Boyle, G. ;
Snyder, J. J. ;
Kasiske, B. L. ;
Israni, A. K. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 :11-46
[9]   Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey [J].
He, S. Y. ;
Makhzoumi, Z. H. ;
Singer, J. P. ;
Chin-Hong, P. V. ;
Arron, S. T. .
TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (01) :14-20
[10]   The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients [J].
Humar, A. ;
Lebranchu, Y. ;
Vincenti, F. ;
Blumberg, E. A. ;
Punch, J. D. ;
Limaye, A. P. ;
Abramowicz, D. ;
Jardine, A. G. ;
Voulgari, A. T. ;
Ives, J. ;
Hauser, I. A. ;
Peeters, P. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) :1228-1237